Blood thinner trial for lung cancer patients on treatment
Treatments studied
Part of Blood & lymphatic, Cancer, Lungs & breathing clinical trials.
This trial tests if apixaban, a blood thinner pill, can prevent dangerous blood clots in people with advanced lung cancer who are receiving outpatient chemotherapy or other systemic treatments. It aims to reduce the risk of venous thromboembolism (blood clots in veins) during cancer therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older.
- You have advanced lung cancer (stage 3 or 4) that has spread or come back after treatment.
- You are starting a new course of chemotherapy, targeted therapy, or chemoradiation as an outpatient.
- You do not have active bleeding or a high risk for serious bleeding.
- Your kidney and liver function are adequate (no severe kidney or liver failure).
- You are not pregnant, breastfeeding, or taking other blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
This trial tests different ways to take the blood thinner apixaban to prevent blood clots in people with cancer who are starting or switching their cancer treatment. It aims to find the best dose for safety and effectiveness.
This trial compares lower doses of two common blood thinner pills (apixaban and rivaroxaban) to a daily injection (enoxaparin) to prevent blood clots in people receiving treatment for blood cancers like multiple myeloma, lymphoma, or certain other blood cancers.
This study tests personalized blood thinner treatments for people with blood clots in their lungs. It looks for patients who are older, have kidney problems, or have cancer, to see if adjusting the treatment helps them more.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This trial tests whether taking a blood thinner pill for 30 days after spine surgery helps prevent dangerous blood clots. It may help people recovering from surgery for cancer that has spread to the spine.
Hear when a new Thromboprophylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.